*FINAL REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *FINAL REMINDER* PressReach · Nov 28, 2022
Late-Breaking Post-Market Study Data Reinforce Clinical Procedural Success and Safety of the ACURATE neo2(TM) Aortic Valve System PressReach · Nov 28, 2022
Quest Diagnostics Completes Acquisition of Outreach Lab Services Business of Summa Health PressReach · Nov 28, 2022
EDWARDS ANNOUNCES ONE-YEAR DATA ON TRANSFEMORAL TRANSCATHETER TRICUSPID VALVE REPLACEMENT PressReach · Nov 28, 2022
Kintara Therapeutics Granted Fast Track Designation from FDA for REM-001 for Cutaneous Metastatic Breast Cancer PressReach · Nov 28, 2022
Philips debuts new AI-enhanced informatics solutions to increase diagnostic confidence with intelligence at every step of the radiology workflow at RSNA PressReach · Nov 28, 2022
EVOLENT HEALTH ANNOUNCES ACQUISITION OF SPECIALTY ASSET NIA AND STRATEGIC PARTNERSHIP WITH CENTENE PressReach · Nov 18, 2022
Canadian Migraine Sufferers Have New Treatment Option - Health Canada Approves UBRELVY® (ubrogepant tablet) PressReach · Nov 17, 2022
Astellas Announces Zolbetuximab Meets Primary Endpoint in Phase 3 SPOTLIGHT Trial as First-Line Treatment in Claudin 18.2 Positive, HER2-Negative Locally Advanced or Metastatic Gastric and Gastroesophageal Junction (GEJ) Cancers PressReach · Nov 17, 2022
ConferMED, through Grant from the Quest Diagnostics Foundation, now Providing Specialty eConsults to Front Line Primary Care Providers at Federally Qualified Health Centers in Five Key Metropolitan Areas PressReach · Nov 17, 2022